--- title: "Claims Testing for Rx Pharma Product Managers | Minds" canonical_url: "https://getminds.ai/use-cases/claims-testing-for-product-managers-in-rx-pharma" last_updated: "2026-06-16T04:47:13.733Z" meta: description: "Optimize your Rx communication for general practitioners. Minds simulates healthcare professionals for precise claims testing in under an hour." "og:description": "Optimize your Rx communication for general practitioners. Minds simulates healthcare professionals for precise claims testing in under an hour." "og:title": "Claims Testing for Rx Pharma Product Managers | Minds" "twitter:description": "Optimize your Rx communication for general practitioners. Minds simulates healthcare professionals for precise claims testing in under an hour." "twitter:title": "Claims Testing for Rx Pharma Product Managers | Minds" --- June 15, 2026·Use-case·Minds Team # **Claims Testing for Rx Pharma Product Managers | Minds** Optimize your Rx communication for general practitioners. Minds simulates healthcare professionals for precise claims testing in under an hour. [Request Methodology Deep Dive](https://getminds.ai/?register=true) Rx product managers in Germany optimize their scientific communication with healthcare professionals through precise, data-driven target audience simulations. The platform makes it possible to comprehensively test medical promotional messages, positioning, and campaign claims on virtual general practitioner segments before the official field force launch. With an average alignment of 85 to 95 percent compared to traditional, physical panels, Minds delivers reliable qualitative insights in under an hour, proactively preventing marketing missteps. ## The job to be done Launching a new indication or repositioning an established prescription drug requires highly precise communication with healthcare professionals. Product managers in German Rx pharma face the daily challenge of translating complex clinical trial data into clear, compelling, and legally compliant core messages for busy general practitioners. Before the field force is sent out for practice visits with new sales arguments, detail aids, and digital presentations, there must be no doubt about which messages immediately clarify therapeutic relevance and which formulations trigger skepticism or misunderstanding. A false start in the field is extremely costly, as physicians' attention is a scarce commodity and lost trust is incredibly difficult to regain. Marketing and insights teams must therefore validate in advance how different segments of general practitioners react to specific claims, what objections arise, and how scientific evidence is most effectively conveyed. The goal is to find the optimal balance between scientific depth and rapid comprehension in a hectic daily practice environment, without losing valuable time in the real market. ## What today's workflow looks like (and where it breaks) The traditional process for testing promotional messages usually relies on classic physician panels, focus groups, quantitative surveys via specialized market research agencies, or lengthy internal alignments based on agency briefings. In practice, however, these methods hit tight limits. Recruiting office-based GPs in Germany is extremely difficult, time-consuming, and associated with immense honorarium costs, as medical professionals have very little free time to spare for market research studies. It often takes several weeks or even months to gather a statistically relevant number of responses, which severely bottlenecks the agile campaign approval process. Furthermore, physical panels often suffer from selection bias, as participants are primarily physicians who already have an affinity for surveys. The results then fail to reflect the true breadth of the target audience. By the time the agency finally delivers the report, the campaign window is often nearly closed, and short-term adjustments to the claims are barely possible due to time pressure. A/B testing in the live market is out of the question for Rx products due to strict regulatory requirements. ## The Minds workflow - Step 1: Data anchoring at Level 01. You feed the system with your existing data sources, such as CRM insights, previous market studies, anonymized field force reports, or existing quantitative surveys. This ensures that no persona is based on pure assumptions, but that all models are firmly anchored in the reality of the German healthcare market. - Step 2: Target audience segmentation at Level 02. You configure specific segments of German general practitioners. In doing so, you use established demographic and psychographic behavioral models to differentiate target groups by practice size, regional distribution, prescribing behavior in specific indication areas, or general openness to new therapeutic approaches. - Step 3: Input of test claims. You upload the various drafts of your scientific messages, detailer pages, slogans, or drafts for the field force presentation directly into the platform. Even complex medical issues and study results can be entered directly as a stimulus. - Step 4: Configuration of simulation parameters. You define which specific questions should be investigated. This includes the clarity of the clinical data, relevance to daily practice, potential compliance concerns under the German Advertising of Medicines Act (Heilmittelwerbegesetz), or the emotional impact of the messaging. - Step 5: Running the simulation. Minds generates up to 10,000 detailed responses from the simulated physician segments in under an hour. This process requires no physical recruitment, saving both your budget and your time. - Step 6: Analysis of objection mapping and language alignment. You receive a structured evaluation showing exactly which claims face rejection, where misunderstandings regarding the study data lie, and which formulations achieve the highest acceptance. You see precisely which medical terminology is preferred by the physicians. - Step 7: Validation at Level 03. The simulation results are automatically cross-referenced with established demographic and psychographic models as well as official data from the Statistisches Bundesamt, Eurostat, and other national registries to ensure an 85 to 95 percent alignment with traditional panels. ## Sample output In a simulation of a new first-line therapy for type 2 diabetes, a clear picture emerged among simulated general practitioners in North Rhine-Westphalia. While the primary claim regarding significant HbA1c reduction was well received by research-oriented physicians in urban areas, over seventy percent of more conservatively prescribing rural doctors immediately raised concerns about the potential risk of hypoglycemia in daily practice. Thanks to this detailed objection mapping, product management was able to anchor the accompanying safety data and dosing instructions directly in the primary line of reasoning. In the follow-up simulation, the optimized claim achieved a forty-five percent higher acceptance rate, preventing a costly misstep by the field force during the subsequent real-world launch in the German market. This allowed the messaging adjustments to be completed and validated within a single afternoon, well before the final approval of the printed materials. ## Why this beats the alternative Simulating busy healthcare professionals with Minds offers a decisive advantage over traditional focus groups, time-consuming physician surveys, or inaccurate internal estimates. Instead of waiting weeks for feedback from hard-to-reach GPs and paying high recruitment honorariums per participant, product managers get deep qualitative insights in a fraction of the time. This makes it possible to systematically eliminate communication barriers and misunderstandings before the expensive field force campaign even begins. The cost of the simulation is a fraction of the expense of a traditional panel, completely without the risk of sampling errors or delays. Because Minds is hosted exclusively on EU servers and processes no personal data from real physicians, the entire process is also fully GDPR-compliant and meets the strict compliance requirements of the pharmaceutical industry in Germany. It is important to emphasize that Minds serves purely as a simulation platform for optimizing messages, positioning, and concepts. The platform is explicitly not designed for clinical or regulatory trials, representative price elasticity analyses, or political polling. ## Next step Prepare your next field force launch with maximum data security and scientific precision. Use our detailed methodology deep dive to understand how Minds' three-level validation can predict the reactions of German general practitioners with an average accuracy of 85 to 95 percent, and up to 100 percent for specific questions. Learn how you can accelerate your claims testing processes, increase your marketing efficiency, and optimize communication with healthcare professionals. Visit [getminds.ai](https://getminds.ai) to request the complete methodological guide and schedule your first simulation.